Tpg Gp A, Llc bought $20.2M of Sionna Therapeutics (SION)
Executed Feb 10 2025, disclosed Feb 12 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Feb 12 2025), the stock returned -14.8% (delay-adjusted); from the execution session (Feb 10 2025), -31.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
Tpg Gp A, Llc (Other) filed 9 Form 4 reports as a reporting entity in the trailing twelve months (5 purchases, 4 sales), most often in LifeStance Health Group, Inc. (LFST). Across 1 priced purchase filing, the average 21-session return was +3.2% from execution and -6.9% from disclosure (delay-adjusted; derived). The largest single filing was $226.8M of LFST (28,281,943 sh × $8.02, as filed), executed May 12.
Healthcare · Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibros…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→